Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Genedx Holdings Corp (WGS)

Genedx Holdings Corp (WGS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,905,938
  • Shares Outstanding, K 27,471
  • Annual Sales, $ 202,570 K
  • Annual Income, $ -175,770 K
  • EBIT $ -58 M
  • EBITDA $ -24 M
  • 60-Month Beta 2.11
  • Price/Sales 9.63
  • Price/Cash Flow N/A
  • Price/Book 9.54

Options Overview Details

View History
  • Implied Volatility 83.77% ( +1.33%)
  • Historical Volatility 134.01%
  • IV Percentile 16%
  • IV Rank 4.86%
  • IV High 422.65% on 11/24/23
  • IV Low 66.46% on 01/10/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 39
  • Volume Avg (30-Day) 962
  • Put/Call OI Ratio 0.49
  • Today's Open Interest 6,108
  • Open Int (30-Day) 8,452

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.20
  • Number of Estimates 1
  • High Estimate 0.20
  • Low Estimate 0.20
  • Prior Year -0.59
  • Growth Rate Est. (year over year) +133.90%

Price Performance

See More
Period Period Low Period High Performance
1-Month
55.30 +33.38%
on 10/23/24
89.11 -17.23%
on 10/30/24
+15.57 (+26.76%)
since 10/21/24
3-Month
28.86 +155.58%
on 09/05/24
89.11 -17.23%
on 10/30/24
+39.26 (+113.80%)
since 08/21/24
52-Week
1.32 +5,487.88%
on 11/22/23
89.11 -17.23%
on 10/30/24
+72.36 (+5,168.57%)
since 11/21/23

Most Recent Stories

More News
Meet the Healthcare Stock That Produced Nvidia-Sized Gains in Less Than a Year

Cautious investors have long known that healthcare spending rises steadily regardless of the direction of the overall economy. It's considered a defensive sector, but it still contains stocks that can...

NVDA : 144.66 (-0.84%)
WGS : 71.50 (+3.06%)
New Strong Buy Stocks for November 4th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Capitol Federal Financial, Inc. CFFN: This holding company for Capitol Federal Savings Bank has seen the Zacks Consensus Estimate...

WGS : 71.50 (+3.06%)
CFFN : 6.68 (+0.30%)
NBBK : 20.01 (+0.40%)
ISBA : 24.8900 (-0.40%)
VLRS : 7.99 (-0.75%)
GeneDx - AI Healthcare Leader

Summary GeneDx Holdings Corp. offers AI-driven genomics-related diagnostic services, focusing on pediatrics, rare diseases, and hereditary cancer screening, with significant recent price appreciation....

WGS : 71.50 (+3.06%)
PacBio and GeneDx Launch Research Collaboration with the University of Washington to Study Long-Read Whole Genome Sequencing for Increased Diagnostic Yield in Neonatal Care

/PRNewswire/ -- PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate sequencing solutions and GeneDx (Nasdaq: WGS), a leader in...

PACB : 1.7100 (-0.58%)
WGS : 71.50 (+3.06%)
Why GeneDx Holdings Stock Lagged the Market Today

A financial-engineering move about to be made by the company is an indication of some deep and challenging problems.

WGS : 71.50 (+3.06%)
NDAQ : 80.25 (+0.21%)
Why Shares of GeneDx Dropped Wednesday

The potential of a reverse split concerned investors.

WGS : 71.50 (+3.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

GeneDx Holdings Corp. is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets. GeneDx Holdings Corp., formerly known as Sema4 Holdings Corp., is based in STAMFORD, Conn.

See More

Key Turning Points

3rd Resistance Point 74.67
2nd Resistance Point 73.07
1st Resistance Point 71.22
Last Price 71.50
1st Support Level 67.77
2nd Support Level 66.17
3rd Support Level 64.32

See More

52-Week High 89.11
Last Price 71.50
Fibonacci 61.8% 55.57
Fibonacci 50% 45.21
Fibonacci 38.2% 34.86
52-Week Low 1.32

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar